The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR
NCT00371020 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2007-07-12
Summary
To evaluate the effect of combined 5-FU and low molecular weight heparin in infusion on the rate of retinal redetachment after silicone oil removal in cases of proliferative vitreoretinopathy (PVR).
Conditions
- Proliferative Vitreoretinopathy
Interventions
- DRUG
-
low molecular weight heparin, 5-FU
Sponsors & Collaborators
-
Shahid Beheshti University of Medical Sciences
lead OTHER
Principal Investigators
-
Hamid Ahmadieh, MD · Ophthalmic Research Center of Shaheed Beheshti Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-02-28
- Completion
- 2007-07-31
Countries
- Iran
Study Locations
More Related Trials
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT01724385 ·Status: COMPLETED ·Phase: PHASE4
-
Repeated Methotrexate for Proliferative Vitreoretinopathy Grade C
NCT04482543 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients
NCT00524875 ·Status: UNKNOWN ·Phase: NA
-
Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
NCT00548197 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
NCT00370201 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
NCT00370786 ·Status: COMPLETED ·Phase: PHASE3
-
Preoperative Bevacizumab for Vitreous Hemorrhage
NCT00596297 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of the Adjunctive IVB Before PRP
NCT01504724 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
NCT04511715 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intravitreal Bevacizumab for Diabetic Retinopathy
NCT00600262 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients
NCT03391219 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
NCT01025934 ·Status: COMPLETED ·Phase: PHASE4
-
Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage
NCT01151722 ·Status: UNKNOWN ·Phase: PHASE2
-
Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy
NCT00347698 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
NCT00370851 ·Status: COMPLETED ·Phase: PHASE3
-
Bevacizumab and Retinal Vascular Occlusions
NCT00347711 ·Status: WITHDRAWN ·Phase: PHASE3
-
Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
NCT00383812 ·Status: UNKNOWN ·Phase: NA
-
Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV
NCT02590094 ·Status: COMPLETED ·Phase: NA
-
Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization
NCT01350323 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
NCT00407121 ·Status: WITHDRAWN ·Phase: PHASE3
-
Major and Macular Branched Retinal Venous Occlusion
NCT01219205 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR
NCT04800679 ·Status: UNKNOWN ·Phase: PHASE2
-
Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema
NCT00571142 ·Status: TERMINATED ·Phase: PHASE3
-
Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
NCT00802126 ·Status: COMPLETED ·Phase: PHASE1
-
Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy
NCT00745498 ·Status: COMPLETED ·Phase: NA